Publications

RÖDROCK – Randomiserad kontrollerad studie över metoder att öka deltagande i Regionens organiserade cellprovskontroll (ROCK) och minska förekomsten av livmoderhalscancer

Björn Strander, 2009-04-24

Repeat hrHPV testing using Qvintip self collection at home is cost-effective in the cervical cancer prevention program.

Reference: Östensson et al, Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program, Acta Obstet Gynecol Scand, 2013 Aug,92(8):994

http://www.ncbi.nlm.nih.gov/pubmed/23530870

Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis

Marc Arbyn, Freija Verdoodt, Peter J F Snijders, Viola M J Verhoef, Eero Suonio, Lena Dillner, Silvia Minozzi, Cristina Bellisario, Rita Banzi, Fang-Hui Zhao, Peter Hillemanns, Ahti Anttila

Summary
Background. Screening for human papillomavirus (HPV) infection is more effective in reducing the incidence of cerivial cancer than screening using Pap smears. Moreover, HPV testing can be done on a vaginal sample self-taken by a woman, which offers an opporunity to improve screening coverage. However, the clinical accuracy of HPV testing on self-samples is not well-known. We assessed eheter HPV testing on self-collected samples is equivalent to HPV testing on samples cellected by clinicians.


Qvintip® − Tested in Trials on over 9,000 Subjects

Qvintip has been evaluated in partnership with Uppsala University Hospital. A total of over 9,000 women have been involved in trials, of which over 3,000 used Qvintip. References to the most important publications are provided below.


Other relevant references

Menu